5-MeO-DMT Fumarate Crystallization via Low-Temperature Cooling
Solution Overview
Problem
Existing methods fail to produce a crystalline form of 5-methoxy-N,N-dimethyltryptamine fumarate effectively, with attempts resulting in a suspension rather than a crystalline solution, and it is unclear how deuterated analogues would behave in terms of polymorphs.
Innovation Solution
A method involving dissolving 5-methoxy-N,N-dimethyltryptamine in ethanol at low temperatures (15° C to 75° C), contacting it with fumaric acid, stirring, and cooling to collect crystalline fumarate salts, which surprisingly yields at least three distinct polymorphs of 5-MeO-DMT fumarate and its deuterated analogues.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If the method of WO 2021/089873 (heating at 70-100°C) is used to produce crystalline fumarate salts, then crystalline DMT fumarate can be obtained, but 5-MeO-DMT fumarate does not form a solution and fails to produce crystals
Solution Approach 1:
The patent changes the temperature parameter from high (70-100°C) to low (15-75°C) to enable crystallization of 5-MeO-DMT fumarate. This parameter change resolves the contradiction by finding optimal conditions where 5-MeO-DMT fumarate successfully forms crystals, unlike the previous method which failed completely for this compound.
Solution Approach 2:
Instead of following the conventional high-temperature approach that worked for DMT but failed for 5-MeO-DMT, the patent inverts the temperature approach by using low temperatures (15-75°C). This inversion of the temperature parameter successfully produces crystalline 5-MeO-DMT fumarate where the conventional method failed.
2Adaptability or versatility
If deuterated analogues are produced using conventional methods, then a single polymorph is expected, but three distinct polymorphs are actually obtained
Solution Approach 1:
The low temperature parameter range (15-75°C) enables the formation of multiple polymorphs that would not form at higher temperatures. This parameter change increases polymorph diversity while maintaining manufacturing precision through controlled crystallization conditions.
Solution Approach 2:
The patent utilizes phase transitions during cooling to generate multiple polymorphic forms. By controlling the temperature reduction from 75°C to 15°C, different crystalline phases are stabilized, resulting in three distinct polymorphs with characteristic PXRD patterns.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides crystalline fumarate salts of 5-MeO-DMT with excellent yield and stability, characterized by specific PXRD patterns, and demonstrates therapeutic potential for psychiatric and neurological disorders.
Implementation Method 1
Dissolving a freebase of the 5-methoxy-N,N-dimethyltryptamine compound in ethanol at a temperature of about 15° C. to about 75° C. to form an ethanolic solution; contacting the ethanolic solution of the 5-methoxy-N,N-dimethyltryptamine compound with fumaric acid; cooling the mixture to between about 5° C. and about 0° C.; and filtering the mixture to collect the crystalline fumarate salt
Implementation Method 2
cooling the mixture to between about 5° C. and about 0° C.
Implementation Method 3
cooling the mixture to between about 5° C. and about 0° C.; and filtering the mixture to collect the crystalline fumarate salt
Data Source
AI summary
Described herein are crystalline fumarate salts having a Formula I, pharmaceutical formulations comprising the same, methods for their production, and uses thereof, Formula I comprising:wherein each R1 is independently selected from protium and deuterium; each R2 is independently selected from protium and deuterium; each R3 is independently selected from protium and deuterium; and each R4 is independently selected from protium and deuterium; and wherein the compound has a PXRD pattern comprising characteristic peaks at 19.2±0.2 and 24.7±0.2 degrees 2-theta.



